×
Deliberate Self-Harm in Young People: Characteristics and Subsequent Mortality in a 20-Year Cohort of Patients Presenting to Hospital PDF
$ 40.00
Deliberate Self-Harm in Young People: Characteristics and Subsequent Mortality in a 20-Year Cohort of Patients Presenting to Hospital PDF quantity
$ 40.00
×
Predicting the Short-Term Outcome of First Episodes and Recurrences of Clinical Depression: A Prospective Study of Life Events, Difficulties, and Social Support Networks PDF
$ 40.00
Predicting the Short-Term Outcome of First Episodes and Recurrences of Clinical Depression: A Prospective Study of Life Events, Difficulties, and Social Support Networks PDF quantity
$ 40.00
×
Psychotic Exacerbation Following Subcutaneous Leuprolide in a Male Patient With Previous History of Schizophrenia PDF
$ 40.00
Psychotic Exacerbation Following Subcutaneous Leuprolide in a Male Patient With Previous History of Schizophrenia PDF quantity
$ 40.00
×
Positron Emission Tomography Measurement of Dopamine D2 Receptor Occupancy in the Pituitary and Cerebral Cortex: Relation to Antipsychotic-Induced Hyperprolactinemia PDF
$ 40.00
Positron Emission Tomography Measurement of Dopamine D2 Receptor Occupancy in the Pituitary and Cerebral Cortex: Relation to Antipsychotic-Induced Hyperprolactinemia PDF quantity
$ 40.00
×
Novel Quality Control Metric for the Pharmacotherapy of Major Depressive Disorder: Measuring Guideline Concordance and Its Impact on Symptom Severity PDF
$ 40.00
Novel Quality Control Metric for the Pharmacotherapy of Major Depressive Disorder: Measuring Guideline Concordance and Its Impact on Symptom Severity PDF quantity
$ 40.00
×
Familial Psychiatric Illness and Posttraumatic Stress Disorder: Findings From a Family Study of Substance Abuse and Anxiety Disorders. PDF
$ 40.00
Familial Psychiatric Illness and Posttraumatic Stress Disorder: Findings From a Family Study of Substance Abuse and Anxiety Disorders. PDF quantity
$ 40.00
×
Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications PDF
$ 40.00
Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications PDF quantity
$ 40.00
×
The Communication Gap Between the Medical System and Community Resources for Dementia-Related Behavioral Symptom Management: Family Caregiver Perspectives PDF
$ 40.00
The Communication Gap Between the Medical System and Community Resources for Dementia-Related Behavioral Symptom Management: Family Caregiver Perspectives PDF quantity
$ 40.00
×
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF
$ 40.00
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Alcohol and Cannabis Use in Urban, African American, First-Episode Schizophrenia-Spectrum Patients: Associations With Positive and Negative Symptoms PDF
$ 40.00
Alcohol and Cannabis Use in Urban, African American, First-Episode Schizophrenia-Spectrum Patients: Associations With Positive and Negative Symptoms PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
